SCINAI IMMUNOTHERAPEUTICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4724 USD | -2.15% |
|
+5.47% | -20.66% |
Financials (USD)
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 2.06M |
|---|---|---|---|---|---|
| Net income 2023 * | -7M | Net income 2024 * | - | EV / Sales 2023 * | - |
| Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
-0.27
x | P/E ratio 2024 * |
-
| Employees | 33 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.64% |
More Fundamentals
* Assessed data
More news
Latest transcript on Scinai Immunotherapeutics Ltd.
More press releases
| 1 day | -2.15% | ||
| 1 week | +5.47% | ||
| Current month | -8.98% | ||
| 1 month | -8.49% | ||
| 3 months | -12.50% | ||
| 6 months | -28.53% | ||
| Current year | -20.66% |
1 week
0.44
0.48
1 month
0.430.52
Current year
0.430.65
1 year
0.432.27
3 years
0.4341.90
5 years
0.43620.00
10 years
0.43620.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 0.4724 | -2.15% | 19,195 |
| 24-04-23 | 0.4828 | +5.19% | 8,697 |
| 24-04-22 | 0.459 | -1.50% | 10,066 |
| 24-04-19 | 0.466 | +2.19% | 14,785 |
| 24-04-18 | 0.456 | +1.81% | 5,387 |
Delayed Quote Nasdaq, April 24, 2024 at 04:30 pm EDT
More quotes
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Companyâs core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Calendar
2024-04-29
- Q4 2023 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4724
USD
Average target price
70
USD
Spread / Average Target
+14,717.95%
| 1st Jan change | Capi. | |
|---|---|---|
| -20.66% | 2.06M | |
| +4.09% | 43.84B | |
| +46.23% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
- Stock Market
- Equities
- SCNI Stock
